Related Experiment Video
Updated: Aug 30, 2025

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel
Vincenza Barresi1, Camillo Musmeci1, Alessandro Rinaldi1
1Section of Medical Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
RNA interference (RNAi) and antisense oligonucleotides (ASOs) offer novel genetic disease and cancer therapies by targeting specific RNA. These precision medicines are revolutionizing treatment by silencing RNA, arresting translation, or modifying protein expression.
Area of Science:
- Molecular Biology
- Genetics
- Pharmacology
Background:
- RNA interference (RNAi) and antisense oligonucleotides (ASOs) represent rapidly advancing therapeutic modalities.
- These technologies target specific RNA sequences for therapeutic benefit in genetic diseases and cancer.
More Related Videos
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
MicroRNAs
Types of RNA
RNA Performs Diverse...

